Atlas Trials

Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)

Clinical trial NCT04900428 · TERMINATED

Trial details

NCT number
NCT04900428
Sponsor
Sorrento Therapeutics, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2021-07-16
Primary completion
2022-03-22
Enrollment
179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.